Business Wire

Renowned French Sommeliers Appointed as Ambassadors for “Awasake,” a Sparkling Japanese Sake Exported to Over 25 Countries and Regions Throughout the World!

Share

The Japan Awasake Association (Representative Director: Noriyoshi Nagai, President of Nagai Sake Inc.), an association established by brewers of sparkling Japanese sake “Awasake,” which is produced by combining traditional sake production methods with advanced technologies such as secondary fermentation in the bottle, held a press conference at the Kanze Noh Theater, a sanctuary of Japanese traditional culture, in Ginza, Tokyo, on Tuesday, March 9.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210413005529/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Brewers and others who participated in the press conference (Photo: Business Wire)

There are currently 27 brands of Awasake that have been certified through a strict screening process and comply with standards such as being clearly transparent, and having a ray of beautiful and fine bubbles through maturation. Of these, 20 varieties are exported to over 25 countries and regions throughout the world, including the United States, Australia, Hong Kong, and Singapore. In recent years, Awasake has attracted much attention for the rapid increase in the number of sake-related awards it has received overseas.

* March 9, media video of the Certification Ceremony and Appointment Ceremony:
https://www.youtube.com/watch?v=nit7UW1vibg&t=2700s

* List of exported Awasake and history of their awards throughout the world:
http://greencreate.boo.jp/PR/awa.pdf

* Online shopping website of Japanese sake for overseas:
https://japanpage.jp/en/awasake

At this press conference, Mr. Shinya Tasaki, President of the Japan Sommelier Association, highly praised the great compatibility between ‘Awasake’ and French cuisine. Also this year, Mr. Xavier Thuizat and Mr. Philippe Jamesse, both famous French sommeliers, were appointed as Awasake Ambassadors. Furthermore, an original Association Awasake glass supervised by Philippe Jamesse was also unveiled.

“We would like to promote the appeal of sparkling Japanese sake, which has a unique value distinct from champagne and is a world-class, high-value-added product. We would like to make Awasake the toast of the world," said the Association.

* Japan Awasake Association official website:
https://awasake.or.jp/en/

* Japan Awasake Association youtube channel:
https://www.youtube.com/channel/UCnMFNdgRoattkORlFCE2SHQ

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Japan Awasake Association
Public Relations: Tomoko Takiguchi
+81-80-8422-5844
info@greencreate.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 15:00:00 EET | Press release

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release

I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye